Andrew Mcewen is a Study Manager at Syngenta. He possess expertise in bioanalysis, drug discovery, life sciences, pharmaceutical industry, chemistry and 22 more skills. Colleagues describe him as "Having worked with Andrew for more than 15 years I can't think of anyone better from whom to obtain up-to-date and highly relevant DMPK and agrochemical advice. In addition to his wealth of scientific knowledge and experience, Andrew is extremely approachable and easy to work with - in my opinion the perfect partner for any pharmaceutical/agricultural company." and "I had the privilege of collaborating with Andrew in different projects when he was Head of Metabolic Chemistry and Chief Scientist at Quotient BioResearch. He is an experienced DMPK expert with an excellent global view of all DMPK aspects of potential new drugs, with an outstanding experience in the ADME profiling of radiolabelled pharmaceuticals. He is a great person to work with and I have always valued our personal interactions. I have no hesitation recommending Andrew as a high level… Show more"